(MENAFN- GlobeNewsWire - Nasdaq) The probiotics segment in animal growth promoters is rapidly expanding due to rising demand for healthier livestock, regulatory pressures, and emerging markets.
As stated above, Pharma 4.0 involves the implementation of technologies, such as AI, robotics, automation, and computational modeling, that enable the manufacturing of pharmaceutical products with ...
The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...
The global pharmaceutical industry is growing and offers an attractive opportunity for investors. Well-established pharmaceutical stocks include AbbVie, Eli Lilly, Johnson & Johnson, and Pfizer.
In today’s fast-paced world, threats can evolve quickly and without warning. As the pharmaceutical industry has operations and supply chains spanning the globe, companies are vulnerable to ...
The Body Composition Monitor and Scale Market, valued at USD 644.7 Million in 2024, Is Set for Substantial Growth, projected to Reach USD 1.31 Billio ...
October 14, 2024--(BUSINESS WIRE)--H. Lundbeck A/S (Lundbeck) and Longboard Pharmaceuticals, Inc (NASDAQ: LBPH) (Longboard) today announced an agreement for Lundbeck to acquire Longboard.
Australia has committed up to $600 million over a decade to bolster PNG's pitch to secure a team in the competition, with the NRL set to make a final decision in coming weeks. But the ABC revealed ...
VALBY, Denmark & LA JOLLA, Calif.--(BUSINESS WIRE)--H. Lundbeck A/S (Lundbeck) and Longboard Pharmaceuticals, Inc (NASDAQ: LBPH) (Longboard) today announced an agreement for Lundbeck to acquire ...
Recent strategic moves, including partnerships with ExxonMobil and new client acquisitions like Ono Pharmaceutical and Mahindra & Mahindra, highlight its expanding market presence. Despite ...
Ozempic, Wegovy or Mounjaro: the battle of the weight-loss injections - As weight-loss injections emerge as key players in ...
Oct 16 (Reuters) - The U.S. Food and Drug Administration has put on hold a trial of Novavax's (NVAX.O), opens new tab COVID-influenza and its standalone flu vaccines after a participant who took ...